UPDATE : Wednesday, January 23, 2019
Court rejects patent registration for acute myeloid leukemia drug Vyxeos by Lee Hye-seon 2019-01-23 14:47
New HIV combo pill Biktarvy approved in Korea by Lee Hye-seon 2019-01-21 15:36
‘Pharmaceuticals need President Moon’s committed support’ by Lee Hye-seon 2019-01-17 17:39
Intra-articular injection Conjuran recognized as new medical tech by Lee Hye-seon 2019-01-15 14:07
Baxter’s dialyzer suspended due to bad-mouthing rival products by Lee Hye-seon 2019-01-15 11:42
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever by Lee Hye-seon 2019-01-14 14:56
14 drugmakers to release generic copies of Stillen 2X in early February by Lee Hye-seon 2019-01-14 11:34
Dongkoo to test stem cell therapy for diabetic foot ulcers by Lee Hye-seon 2019-01-11 15:53
MSD Korea recalls HIV drug Stocrin with particular code by Lee Hye-seon 2019-01-10 11:46
Regulator keeps Kyung Nam Pharm listed with 1-year grace period by Lee Hye-seon 2019-01-09 14:49
Handok and Genexine become largest stakeholder of Rezolute by Lee Hye-seon 2019-01-08 14:53
New influenza drug to be tested in phase-3 trial in Korea by Lee Hye-seon 2019-01-07 15:30
Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution by Lee Hye-seon 2019-01-07 12:46
5 pharmaceuticals’ growth strategies for 2019 by Lee Hye-seon 2019-01-02 16:25
CEO of insulin pump maker embroiled in ‘gapjil’ controversy by Lee Hye-seon 2018-12-28 14:10
Withus Pharmaceutical punished for skipping quantitative test by Lee Hye-seon 2018-12-21 15:37
Astellas Korea rebuked for arbitrarily modifying trials by Lee Hye-seon 2018-12-20 11:05
Drugmaker booked for bribing doctors with propofol discounts by Lee Hye-seon 2018-12-19 14:12
Handok to test new insomnia drug in phase-3 study by Lee Hye-seon 2018-12-19 11:44
Kyung Nam Pharm shareholders lambast delisting decision by Lee Hye-seon 2018-12-17 11:57
Back to Top